Corbus Pharmaceuticals Holdings, Inc. Class of Warrant or Right, Outstanding
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Class of Warrant or Right, Outstanding of 2.28 million shares as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2018-11-08
- 2018-09-30: Class of Warrant or Right, Outstanding 2.28M shares.
- 2018-06-30: Class of Warrant or Right, Outstanding 2.29M shares.
- 2018-03-31: Class of Warrant or Right, Outstanding 2.29M shares.
- 2017-09-30: Class of Warrant or Right, Outstanding 1.29M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2018-09-30 | 2.28M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 2.29M shares 10-Q · filed 2018-08-08 |
| 2018-03-31 | 2.29M shares 10-Q · filed 2018-05-10 |
| 2017-09-30 | 1.29M shares 10-Q · filed 2017-11-08 |
| 2017-06-30 | 1.29M shares 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |